title: The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 microm) bolus aerosols.
abstract: The influence of particle size upon deposition in the human airways is well understood. Pharmaceutical aerosol formulators strive to generate fine aerosols with the potential to penetrate into the deep lung. However, flow rate can also have a major influence on deposition, particularly with coarse aerosols. This study investigated the use of biphasic flow profiles with low flow in the proximal conducting airway as a means of effecting efficient delivery of a coarse aerosol. The study shows that 6.5-microm MMAD aerosol droplets can be deposited in the lung with high efficiency. The delivery technique achieved greater than 70% of the inhaled dose deposited in the whole lung and greater than 50% deposited in the lung periphery. Furthermore, the biphasic flow profiles used, with initial low flow segments of between 300 mL and 900 mL inhaled volume at 8 L/min, are practical flow regimens that should be acceptable to patients and that can be applied to single-breath dry powder inhalers. Twenty-four-hour clearance and Penetration Index measurements were used as a marker for peripheral deposition, and the data show a clear correlation between Penetration Index and 24-h retention.
authors: Nektar Therapeutics, San Carlos, California, USA. aclark@ca.nektar.com
authors: Andrew R
authors: AR
authors: Clark
authors: Carole B
authors: CB
authors: Chambers
authors: David
authors: D
authors: Muir
authors: Michael T
authors: MT
authors: Newhouse
authors: Steven
authors: S
authors: Paboojian
authors: Carlos
authors: C
authors: Schuler
mesh_terms: D000328:Adult; D000336:Aerosols / Q000008:administration & dosage / Q000493:pharmacokinetics; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D001239:Inhalation / Q000502:physiology*; D007834:Lasers; D008168:Lung / Q000378:metabolism*; D008297:Male; D009960:Oropharynx / Q000378:metabolism; D010316:Particle Size; D011208:Powders; D019946:Propylene Glycol / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011650:Pulmonary Alveoli / Q000378:metabolism; D019275:Radiopharmaceuticals; D012212:Rheology; D016037:Single-Blind Method; D013147:Spirometry; D013671:Technetium Tc 99m Sulfur Colloid; D014109:Total Lung Capacity / Q000502:physiology
chemical_list: D000336:Aerosols; D011208:Powders; D019275:Radiopharmaceuticals; D013671:Technetium Tc 99m Sulfur Colloid; D019946:Propylene Glycol